Part Number
Part Number:
NSN:
NIIN:
Item Name:
THEOPHYLLINE EXTENDED-RELEASE CA
Definition:
CAGE Information
| Code | Company |
|---|---|
| 04518 | AVENTIS PHARMACEUTICALS PRODUCTS INC |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CQLS | CAPSULE CONTENT FORM | ANY ACCEPTABLE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 100S |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
| FEAT | SPECIAL FEATURES | ANHYDROUS |
| THPE | THERAPEUTIC EQUIVALENT | SLO-BID GYROCAPS BY RORER PHARMACEUTICAL |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |